Transactions
$115 Million
Co-Lead Placement Agent
Private Placement
April 2022
UNDISCLOSED
Financial Advisor
Merger with MoonLake Immunotherapeutics
April 2022
$25 Million
Joint Bookrunner
Follow-On
March 2022
$10 Million
Joint Bookrunner
Follow-On
March 2022
$6.0 Billion
Financial Advisor
Sale to Optum Health, a UnitedHealth Group Company
Pending
$69 Million
Joint Bookrunner
Initial Public Offering
March 2022
UNDISCLOSED
Capital Markets and Financial Advisor
Merger with Avista Public Acquisition Corp. II
Pending
$700 Million
Joint Bookrunner
Follow-On
March 2022
UNDISCLOSED
Lead Financial Advisor
Sale to Clearlake Capital Group
Pending
$275 Million
Joint Bookrunner
Convertible Senior Note Offering
March 2022
$1.9 Billion
Financial Advisor
Sale to UCB
March 2022
$75 Million
Joint Bookrunner
Follow-On
March 2022